This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francis, D. A.
Right arrow Articles by Howley, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francis, D. A.
Right arrow Articles by Howley, P. M.

 Previous Article  |  Next Article 

Journal of Virology, March 2000, p. 2679-2686, Vol. 74, No. 6
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells

Delicia A. Francis, Susanne I. Schmid, and Peter M. Howley*

Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115

Received 2 November 1999/Accepted 16 December 1999

The human papillomavirus (HPV) E2 protein is an important regulator of viral E6 and E7 gene expression. E2 can repress the viral promoter for E6 and E7 expression as well as block progression of the cell cycle in cancer cells harboring the DNA of "high-risk" HPV types. Although the phenomenon of E2-mediated growth arrest of HeLa cells and other HPV-positive cancer cells has been well documented, the specific mechanism by which E2 affects cellular proliferation has not yet been elucidated. Here, we show that bovine papillomavirus (BPV) E2-induced growth arrest of HeLa cells requires the repression of the E6 and E7 promoter. This repression is specific for E2TA and not E2TR, a BPV E2 variant that lacks the N-terminal transactivation domain. We demonstrate that expression of HPV16 E6 and E7 from a heterologous promoter that is not regulated by E2 rescues HeLa cells from E2-mediated growth arrest. Our data indicate that the pathway of E2-mediated growth arrest of HeLa cells requires repression of E6 and E7 expression through an activity specified by the transactivation domain of E2TA.


* Corresponding author. Mailing address: Department of Pathology, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-2884. Fax: (617) 432-2882. E-mail: peter_howley{at}hms.harvard.edu.


Journal of Virology, March 2000, p. 2679-2686, Vol. 74, No. 6
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bedard, K. M., Underbrink, M. P., Howie, H. L., Galloway, D. A. (2008). The E6 Oncoproteins from Human Betapapillomaviruses Differentially Activate Telomerase through an E6AP-Dependent Mechanism and Prolong the Lifespan of Primary Keratinocytes. J. Virol. 82: 3894-3902 [Abstract] [Full Text]  
  • Vinokurova, S., Wentzensen, N., Kraus, I., Klaes, R., Driesch, C., Melsheimer, P., Kisseljov, F., Durst, M., Schneider, A., von Knebel Doeberitz, M. (2008). Type-Dependent Integration Frequency of Human Papillomavirus Genomes in Cervical Lesions. Cancer Res. 68: 307-313 [Abstract] [Full Text]  
  • Topffer, S., Muller-Schiffmann, A., Matentzoglu, K., Scheffner, M., Steger, G. (2007). Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses. J. Gen. Virol. 88: 2956-2965 [Abstract] [Full Text]  
  • Schweiger, M.-R., Ottinger, M., You, J., Howley, P. M. (2007). Brd4-Independent Transcriptional Repression Function of the Papillomavirus E2 Proteins. J. Virol. 81: 9612-9622 [Abstract] [Full Text]  
  • Hoover, A. C., Spanos, W. C., Harris, G. F., Anderson, M. E., Klingelhutz, A. J., Lee, J. H. (2007). The Role of Human Papillomavirus 16 E6 in Anchorage-Independent and Invasive Growth of Mouse Tonsil Epithelium. Arch Otolaryngol Head Neck Surg 133: 495-502 [Abstract] [Full Text]  
  • Jing, M., Bohl, J., Brimer, N., Kinter, M., Vande Pol, S. B. (2007). Degradation of Tyrosine Phosphatase PTPN3 (PTPH1) by Association with Oncogenic Human Papillomavirus E6 Proteins. J. Virol. 81: 2231-2239 [Abstract] [Full Text]  
  • Johung, K., Goodwin, E. C., DiMaio, D. (2007). Human Papillomavirus E7 Repression in Cervical Carcinoma Cells Initiates a Transcriptional Cascade Driven by the Retinoblastoma Family, Resulting in Senescence. J. Virol. 81: 2102-2116 [Abstract] [Full Text]  
  • Peck, R. B., Schweizer, J., Weigl, B. H., Somoza, C., Silver, J., Sellors, J. W., Lu, P. S. (2006). A magnetic immunochromatographic strip test for detection of human papillomavirus 16 E6.. Clin. Chem. 52: 2170-2172 [Full Text]  
  • Parish, J. L., Kowalczyk, A., Chen, H.-T., Roeder, G. E., Sessions, R., Buckle, M., Gaston, K. (2006). E2 Proteins from High- and Low-Risk Human Papillomavirus Types Differ in Their Ability To Bind p53 and Induce Apoptotic Cell Death. J. Virol. 80: 4580-4590 [Abstract] [Full Text]  
  • Gammoh, N., Grm, H. S., Massimi, P., Banks, L. (2006). Regulation of Human Papillomavirus Type 16 E7 Activity through Direct Protein Interaction with the E2 Transcriptional Activator. J. Virol. 80: 1787-1797 [Abstract] [Full Text]  
  • Wise-Draper, T. M., Allen, H. V., Thobe, M. N., Jones, E. E., Habash, K. B., Munger, K., Wells, S. I. (2005). The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7. J. Virol. 79: 14309-14317 [Abstract] [Full Text]  
  • Psyrri, A., DeFilippis, R. A., Edwards, A. P. B., Yates, K. E., Manuelidis, L., DiMaio, D. (2004). Role of the Retinoblastoma Pathway in Senescence Triggered by Repression of the Human Papillomavirus E7 Protein in Cervical Carcinoma Cells. Cancer Res. 64: 3079-3086 [Abstract] [Full Text]  
  • Horner, S. M., DeFilippis, R. A., Manuelidis, L., DiMaio, D. (2004). Repression of the Human Papillomavirus E6 Gene Initiates p53-Dependent, Telomerase-Independent Senescence and Apoptosis in HeLa Cervical Carcinoma Cells. J. Virol. 78: 4063-4073 [Abstract] [Full Text]  
  • Wells, S. I., Aronow, B. J., Wise, T. M., Williams, S. S., Couget, J. A., Howley, P. M. (2003). Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells. Proc. Natl. Acad. Sci. USA 100: 7093-7098 [Abstract] [Full Text]  
  • Badal, V., Chuang, L. S. H., Tan, E. H.-H., Badal, S., Villa, L. L., Wheeler, C. M., Li, B. F. L., Bernard, H.-U. (2003). CpG Methylation of Human Papillomavirus Type 16 DNA in Cervical Cancer Cell Lines and in Clinical Specimens: Genomic Hypomethylation Correlates with Carcinogenic Progression. J. Virol. 77: 6227-6234 [Abstract] [Full Text]  
  • Hall, A. H. S., Alexander, K. A. (2003). RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa Cells. J. Virol. 77: 6066-6069 [Abstract] [Full Text]  
  • DeFilippis, R. A., Goodwin, E. C., Wu, L., DiMaio, D. (2002). Endogenous Human Papillomavirus E6 and E7 Proteins Differentially Regulate Proliferation, Senescence, and Apoptosis in HeLa Cervical Carcinoma Cells. J. Virol. 77: 1551-1563 [Abstract] [Full Text]  
  • Alazawi, W., Pett, M., Arch, B., Scott, L., Freeman, T., Stanley, M. A., Coleman, N. (2002). Changes in Cervical Keratinocyte Gene Expression Associated with Integration of Human Papillomavirus 16. Cancer Res. 62: 6959-6965 [Abstract] [Full Text]  
  • Hou, S. Y., Wu, S.-Y., Chiang, C.-M. (2002). Transcriptional Activity among High and Low Risk Human Papillomavirus E2 Proteins Correlates with E2 DNA Binding. J. Biol. Chem. 277: 45619-45629 [Abstract] [Full Text]  
  • Lee, D., Kim, H.-Z., Jeong, K. W., Shim, Y. S., Horikawa, I., Barrett, J. C., Choe, J. (2002). Human Papillomavirus E2 Down-regulates the Human Telomerase Reverse Transcriptase Promoter. J. Biol. Chem. 277: 27748-27756 [Abstract] [Full Text]  
  • Peitsaro, P., Hietanen, S., Johansson, B., Lakkala, T., Syrjanen, S. (2002). Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage. Carcinogenesis 23: 1057-1064 [Abstract] [Full Text]  
  • Nagao, S., Yoshinouchi, M., Miyagi, Y., Hongo, A., Kodama, J., Itoh, S., Kudo, T. (2002). Rapid and Sensitive Detection of Physical Status of Human Papillomavirus Type 16 DNA by Quantitative Real-Time PCR. J. Clin. Microbiol. 40: 863-867 [Abstract] [Full Text]  
  • Peitsaro, P., Johansson, B., Syrjanen, S. (2002). Integrated Human Papillomavirus Type 16 Is Frequently Found in Cervical Cancer Precursors as Demonstrated by a Novel Quantitative Real-Time PCR Technique. J. Clin. Microbiol. 40: 886-891 [Abstract] [Full Text]  
  • Goodwin, E. C., DiMaio, D. (2001). Induced Senescence in HeLa Cervical Carcinoma Cells Containing Elevated Telomerase Activity and Extended Telomeres. Cell Growth Differ. 12: 525-534 [Abstract] [Full Text]  
  • Stubenrauch, F., Zobel, T., Iftner, T. (2001). The E8 Domain Confers a Novel Long-Distance Transcriptional Repression Activity on the E8^E2C Protein of High-Risk Human Papillomavirus Type 31. J. Virol. 75: 4139-4149 [Abstract] [Full Text]  
  • Webster, K., Taylor, A., Gaston, K. (2001). Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. J. Gen. Virol. 82: 201-213 [Abstract] [Full Text]  
  • Goodwin, E. C., DiMaio, D. (2000). Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. USA 97: 12513-12518 [Abstract] [Full Text]  
  • Wu, L., Goodwin, E. C., Naeger, L. K., Vigo, E., Galaktionov, K., Helin, K., DiMaio, D. (2000). E2F-Rb Complexes Assemble and Inhibit cdc25A Transcription in Cervical Carcinoma Cells following Repression of Human Papillomavirus Oncogene Expression. Mol. Cell. Biol. 20: 7059-7067 [Abstract] [Full Text]  
  • Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., Hwang, E.-S. (2000). Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 97: 10978-10983 [Abstract] [Full Text]  
  • Kao, W. H., Beaudenon, S. L., Talis, A. L., Huibregtse, J. M., Howley, P. M. (2000). Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase. J. Virol. 74: 6408-6417 [Abstract] [Full Text]  
  • Nishimura, A., Ono, T., Ishimoto, A., Dowhanick, J. J., Frizzell, M. A., Howley, P. M., Sakai, H. (2000). Mechanisms of Human Papillomavirus E2-Mediated Repression of Viral Oncogene Expression and Cervical Cancer Cell Growth Inhibition. J. Virol. 74: 3752-3760 [Abstract] [Full Text]  
  • Wei, Q., Adelstein, R. S. (2002). Pitx2a Expression Alters Actin-Myosin Cytoskeleton and Migration of HeLa Cells through Rho GTPase Signaling. Mol. Biol. Cell 13: 683-697 [Abstract] [Full Text]